TEVA AND TRUMP ADMINISTRATION ANNOUNCE INTENT TO REACH AGREEMENT ON AFFORDABLE MEDICINES AND U.S. SUPPLY-CHAIN SECURITY, WITH TEVA OFFERING A DEDICATED API RESERVE AND CONTINUED U.S. MANUFACTURING INVESTMENT.
TEVA $TEVA AND TRUMP ADMINISTRATION ANNOUNCE INTENT TO REACH DRUG-PRICING DEAL
The company says it remains in active discussions with the administration on an agreement anchored in all four of the president's drug pricing priorities, covering affordable medicines and US supply chain security. Conditions of the negotiation remain confidential, per the company.
JUST IN: Teva and the Trump administration reveal they intend to reach a drug-pricing deal focused on lower costs and stronger U.S. supply chain security.
The Irish Hospital Consultants Association (IHCA) passes a motion advocating a boycott of products by Israeli drugmaker Teva Pharmaceuticals, urging doctors to use clinically appropriate alternatives in protest of the Israeli genocide on Gaza.